Bihao Wu

State Key Laboratory Of Virology And Biosafety
Wuhan, 430207, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration.

A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration.

Journal: Virologica Sinica

Published: March 03, 2026

Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2.

Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2.

Journal: Journal of virology

Published: January 08, 2025

Comparison of C-type Nanoantibody Produced in Different Expression Systems Implying Potential Clinical Applications.

Comparison of C-type Nanoantibody Produced in Different Expression Systems Implying Potential Clinical Applications.

Journal: Molecular pharmaceutics

Published: December 04, 2024

Dynamics of Crossed Acquired Immunity Against SARS-CoV-2 Variants: From Vaccine to Hybrid Immunity in China.

Dynamics of Crossed Acquired Immunity Against SARS-CoV-2 Variants: From Vaccine to Hybrid Immunity in China.

Journal: Journal of medical virology

Published: September 27, 2024

A Novel Circular Delta-XBB15 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS-CoV-2 Variants in Mice.

A Novel Circular Delta-XBB15 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS-CoV-2 Variants in Mice.

Journal: Journal of medical virology

Published: August 05, 2024

A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1.

A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1.

Journal: Virologica Sinica

Published: October 25, 2023

Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.

Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.

Journal: Signal transduction and targeted therapy

Published: March 22, 2023

Humoral and cellular immunity of two-dose inactivated COVID-19 vaccination in Chinese children: A prospective cohort study.

Humoral and cellular immunity of two-dose inactivated COVID-19 vaccination in Chinese children: A prospective cohort study.

Journal: Journal of medical virology

Published: September 22, 2022

An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response.

An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response.

Journal: Frontiers in immunology

Published: July 28, 2022

SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma.

SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma.

Journal: Frontiers in immunology

Published: May 19, 2022

Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents.

Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents.

Journal: Frontiers of medicine

Published: May 01, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026